Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > The Role of Iron in Benign and Malignant Hematopoiesis
Publication

Publications

The Role of Iron in Benign and Malignant Hematopoiesis

Title
The Role of Iron in Benign and Malignant Hematopoiesis
Type
Article in International Scientific Journal
Year
2021
Authors
Sinha, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pereira Reis, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Guerra, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rivella, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 35
Pages: 415-432
ISSN: 1523-0864
Publisher: Mary Ann Liebert
Other information
Authenticus ID: P-00T-915
Abstract (EN): Significance: Iron is an essential element required for sustaining a normal healthy life. However, an excess amount of iron in the bloodstream and tissue generates toxic hydroxyl radicals through Fenton reactions. Henceforth, a balance in iron concentration is extremely important to maintain cellular homeostasis in both normal hematopoiesis and erythropoiesis. Iron deficiency or iron overload can impact hematopoiesis and is associated with many hematological diseases. Recent Advances: The mechanisms of action of key iron regulators such as erythroferrone and the discovery of new drugs, such as ACE-536/luspatercept, are of potential interest to treat hematological disorders, such as beta-thalassemia. New therapies targeting inflammation-induced ineffective erythropoiesis are also in progress. Furthermore, emerging evidences support differential interactions between iron and its cellular antioxidant responses of hematopoietic and neighboring stromal cells. Both iron and its systemic regulator, such as hepcidin, play a significant role in regulating erythropoiesis. Critical Issues: Significant pre-clinical studies are on the way and new drugs targeting iron metabolism have been recently approved or are undergoing clinical trials to treat pathological conditions with impaired erythropoiesis such as myelodysplastic syndromes or beta-thalassemia. Future Directions: Future studies should explore how iron regulates hematopoiesis in both benign and malignant conditions. Antioxid. Redox Signal. 35, 415-432.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 18
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Redox Metabolism in Mitochondria of Trypanosomatids (2013)
Another Publication in an International Scientific Journal
tomas, am; castro, h
Peroxidases of trypanosomatids (2008)
Another Publication in an International Scientific Journal
castro, h; tomas, am
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 22:22:36 | Privacy Policy | Personal Data Protection Policy | Whistleblowing